Scholar Rock Holding (SRRK) Current Leases (2018 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Current Leases of $6.1 million for Q1 2026, up 10.53% year-over-year from $5.5 million in Q1 2025, and up 9.48% quarter-over-quarter from $5.6 million in Q4 2025.
Scholar Rock Holding (SRRK) Current Leases (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Current Leases history runs 9 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Current Leases rose 10.53% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 10.53% YoY), while the FY2025 annual figure was $5.6 million, down 3.88% from the prior year.
- Current Leases for Q1 2026 stood at $6.1 million, up from $5.6 million in the prior quarter.
- The five-year high for Current Leases was $8.1 million in Q3 2022, with the low at $5.2 million in Q2 2025.
- The 5-year median for Current Leases is $7.2 million (2023), against an average of $6.7 million.
- The sharpest annual moves came in 2022 and 2025: Current Leases surged 34.41% in 2022, then dropped 27.85% in 2025.
- Scholar Rock Holding's Current Leases stood at $7.9 million in 2022, then retreated by 5.65% to $7.4 million in 2023, then fell by 22.06% to $5.8 million in 2024, then declined by 3.88% to $5.6 million in 2025, then advanced by 9.48% to $6.1 million in 2026.
- Business Quant data shows SRRK's Current Leases at $6.1 million in Q1 2026, $5.6 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - | 6.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Mn |
| Mar 31, 2026 | 6.08 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 7.64 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.20 Mn |